Sign Up to like & get
recommendations!
0
Published in 2019 at "Nature Reviews Rheumatology"
DOI: 10.1038/s41584-019-0359-7
Abstract: The availability of biosimilars to treat inflammatory diseases has generated concern about changing patients from a bio-originator to its biosimilar to save costs. Studies published in 2019 support the effectiveness and safety of ‘nonmedical switching’…
read more here.
Keywords:
barriers biosimilars;
overcoming barriers;
rheumatology;
biosimilars inflammatory ... See more keywords